Organogenesis Holdings (ORGO) Return on Capital Employed (2017 - 2026)

Organogenesis Holdings' Return on Capital Employed history runs 10 years deep, the most recent figure standing at 6.68% for Q1 2026.

• In Q1 2026, Return on Capital Employed fell 89.0% year-over-year to 6.68%; the TTM figure through Mar 2026 stood at 6.68% (down 89.0% YoY), while the FY2025 annual figure was 2.2%, up 252.0% from the prior year.
• Return on Capital Employed was 6.68% for Q1 2026 at Organogenesis Holdings, down from 2.17% in the prior quarter.
• In the past five years, Return on Capital Employed ranged from a high of 16.46% in Q1 2022 to a low of 6.68% in Q1 2026.
• Historically, Return on Capital Employed has averaged 2.46% across 5 years, with a median of 3.29% in 2023.
• The sharpest annual moves came in 2022 and 2025: Return on Capital Employed slumped 1852 bps in 2022, then jumped 250 bps in 2025.
• A 5-year view of Return on Capital Employed shows it stood at 5.9% in 2022, then tumbled by 44 bps to 3.29% in 2023, then sank by 110 bps to 0.33% in 2024, then surged by 768 bps to 2.17% in 2025, then slumped by 407 bps to 6.68% in 2026.
• The last three Return on Capital Employed figures came in at 6.68% (Q1 2026), 2.17% (Q4 2025), and 2.12% (Q3 2025), per Business Quant data.